The global market for peptide therapies is projected to grow at an outstanding compound annual growth rate (CAGR) of 10.8% from 2023 to 2033, from its estimated value of USD 38.0 billion in 2023 to USD 106.0 billion by 2033.
The Asia Pacific market for peptide-based medications is expanding quickly, and peptide therapies presently hold a 53.7% market share in the global drug development industry. Peptide medications have been utilized to treat metabolic diseases for over a century. Peptide medications are in high demand worldwide due to their many advantages over small conventional molecules.
Future Market Insights, Inc.’s comparative analysis and market growth rate of the global market for peptide therapeutics may indicate a negative BPS growth in the H1-2023 outlook compared to the H1-2023 projected period by 20 BPS, and a negative BPS dip across the H1-2021 duration with 56 Basis Point Share (BPS) is anticipated in H1-2023.
The observed decrease in BPS values can be attributed to the high cost of producing a peptide and the molecule’s short half-life, which results in significant research expenses. Nonetheless, because peptides can target a variety of sites, producers can create innovative peptide therapeutic formulations, which will benefit the industry as a whole.
Factors like research grants and funding, as well as outsourcing production capabilities in compliance with industry and macro norms, can cause changes in the market. On the other hand, developments in peptide-based targeted drug delivery for cancer cells and next-generation treatments could contribute to the market’s overall favorable growth traction.
How Competition Influences the Peptide Therapeutics Market?
There are several significant participants in the moderately competitive peptide therapies industry. For the international expansion of their product portfolios, the leading players are engaged in strategic alliances such as acquisitions and collaborations, coupled with research efforts.
Leading suppliers of peptide therapeutics are concentrating on market expansion through distribution contracts, joint ventures, and white space investigation. Additionally, established businesses are collaborating with regional firms to improve their area presence and boost their manufacturing capabilities.
Key Players
- Eli Lilly and Company
- Ipsen S.A
- Novo Nordisk A/S
- AstraZeneca plc Merck & Co. Inc
- Teva Pharmaceutical Industries Ltd.
Get Full Report Now
Key Segments
By Application:
- Cancer
- Cardiovascular Diseases
- Central Nervous Systems
- Metabolic Disorders
- Infections
- Hematological Disorders
- Gastrointestinal Disorders
- Dermatology
- Respiratory Disorders
- Acromegaly
- Other Applications
By Route of Administration:
- Parenteral Route of Administration
- Mucosal Route of Administration
- Oral Route of Administration
- Transdermal of Route Administration
By Drug Type:
- Branded Drugs
- Generic/Biosimilar Drugs
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
